Shionogi & Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shionogi & Co Ltd with three other
companies in this sector in Japan:
Mitsubishi Tanabe Pharma Corp
sales of 423.98 billion Japanese Yen [US$3.75 billion]
of which 74%
was Domestic Ethical Drug),
Taisho Pharmaceutical Holdings Co Ltd
(279.77 billion Japanese Yen [US$2.48 billion]
of which 64%
was Self-medication), and
Ono Pharmaceutical Co Ltd
(244.80 billion Japanese Yen [US$2.17 billion]
of which 88%
was Products & Goods).
During the year ended March of 2017, sales at
Shionogi & Co Ltd were ¥338.89 billion (US$3.00 billion).
increase of 9.3%
versus 2016, when the company's sales were ¥309.97 billion.